These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21334728)

  • 1. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
    Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
    Wu CC; Su CT; Lee HL; Chung CJ; Huang CY; Pu YS; Lin P; Hsueh YM
    J Urol; 2012 Nov; 188(5):1701-5. PubMed ID: 22998908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
    Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
    Chung CJ; Pu YS; Shiue HS; Lee HL; Lin P; Yang HY; Su CT; Hsueh YM
    Toxicol Lett; 2013 Jan; 216(1):16-22. PubMed ID: 23142425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Han S; Fristad A; Yang Y; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry.
    Yao L; Zheng S; Guan Y; Yang J; Liu B; Wang W; Zhu X
    Anal Chim Acta; 2013 Jul; 788():61-7. PubMed ID: 23845482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
    J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
    Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS
    Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
    Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
    Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
    Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA
    Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.
    Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P
    Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.